Tevogen Inc.
TVGN· Nasdaq
TVGNTevogen Inc.
Filed Aug 14, 2024 · 10-Q · 45 days after period end · 0001493152-24-032294
| Metric | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|
| Net Income | -$9.66M | -$22.18M | $207.00K | -$11.30K |
| EPS Diluted | -$0.04 | -$0.18 | — | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Tevogen Inc. · CIK 1860871 · Engraved from SEC EDGAR
ended Jun 30, 2024 · filed Aug 14, 2024 · 45 d after period end
